Senators jump on Allergan's 'blatantly anti-competitive' Restasis licensing deal

28th September 2017 Uncategorised 0

It didn’t take long for Congress to push back at Allergan’s first-of-a-kind patent deal with the Saint Regis Mohawk Tribe. Four senators are demanding an investigation, saying the move to protect Restasis is another example of pharma “putting profits before patients.”

More: Senators jump on Allergan's 'blatantly anti-competitive' Restasis licensing deal
Source: fierce